Landscapes / Companies

Keymed Biosciences Co.Ltd not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved in China
Next date
CM383, Phase 1 trial completes
Drugs
13
in active trials · 14 in all
Trials
29 active
68 since 2021

Drugs13

DrugHow it worksPartnerStageNext dateDetails
Artificial immunoglobulin
Approved in China Dec 2026Phase 3 trial completes
—
Phase 3 Dec 2026Phase 1/2 trial completes
—
Phase 3 Mar 2027Phase 2 trial completes
—
CSPC Baike (Shandong) Biopharmaceutical
Phase 3 1 Jul 2027Phase 2 trial completes
—
Phase 3 21 Jul 2027Phase 2 trial completes
—
Phase 1/2 Apr 2027Phase 1/2 trial completes
—
Phase 2 30 Jun 2027Phase 2 trial completes
—
Phase 1/2 31 Dec 2028Phase 1/2 trial completes
—
Phase 1/2 31 Dec 2029Phase 1/2 trial completes
—
Phase 1 30 Dec 2026Phase 1 trial completes
—
Phase 1 Jul 2027Phase 1 trial completes
—
Phase 1 Sep 2027Phase 1 trial completes
—
Phase 1 —

About

No active trial
CMG901
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Keymed Biosciences Co.Ltd

Following is part of Solo: you see every change to Keymed Biosciences Co.Ltd the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in